214 related articles for article (PubMed ID: 24025137)
21. Clinical correlation of antimitochondrial antibodies.
Zuber MA; Recktenwald C
Eur J Med Res; 2003 Feb; 8(2):61-70. PubMed ID: 12626283
[TBL] [Abstract][Full Text] [Related]
22. Detection of anti-SP100 antibodies in primary biliary cirrhosis. Comparison of ELISA and immunofluorescence.
Bauer A; Habior A; Kraszewska E
J Immunoassay Immunochem; 2013; 34(4):346-55. PubMed ID: 23859785
[TBL] [Abstract][Full Text] [Related]
23. Serum immunological profile in patients with chronic autoimmune cholestasis.
Romero-Gómez M; Wichmann I; Crespo J; Parés A; Rodrigo L; Alvarez A; Diago M; Pons-Romero F; Sanchez-Munoz D; Aguilar-Reina J; Andrade RJ; Salmeron J; Sánchez-Pobre P; Rebollo JM; Martin-Vivaldi R; Castellano-Megias V; Nuñez-Roldan A; Bruguera M;
Am J Gastroenterol; 2004 Nov; 99(11):2150-7. PubMed ID: 15554996
[TBL] [Abstract][Full Text] [Related]
24. Association between the primary biliary cirrhosis specific anti-sp100 antibodies and recurrent urinary tract infection.
Bogdanos DP; Baum H; Butler P; Rigopoulou EI; Davies ET; Ma Y; Burroughs AK; Vergani D
Dig Liver Dis; 2003 Nov; 35(11):801-5. PubMed ID: 14674671
[TBL] [Abstract][Full Text] [Related]
25. Clinical evaluation of primary biliary cirrhosis in Chinese patients without serum anti-mitochondrial antibody.
Li CP; Hwang SJ; Chan CY; Lee FY; Huang YS; Chang FY; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 1997 Jun; 59(6):334-40. PubMed ID: 9294912
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis.
Invernizzi P; Crosignani A; Battezzati PM; Covini G; De Valle G; Larghi A; Zuin M; Podda M
Hepatology; 1997 May; 25(5):1090-5. PubMed ID: 9141422
[TBL] [Abstract][Full Text] [Related]
27. [Anti-Sp100 and anti-Gp210 in the diagnosis of primary biliary cirrhosis in patients with autoimmune cholangitis].
Romero Gómez M; Wichmann I; Otero Fernández MA; Suárez García E; Grande L; Núñez J; Nevado Santos M; Castro Fernández M
Gastroenterol Hepatol; 1999 Jan; 22(1):11-3. PubMed ID: 10089705
[TBL] [Abstract][Full Text] [Related]
28. [Clinical and pathological analysis on characteristics of primary biliary cirrhosis].
Zhou GD; Zhao JM; Wang SS; Sun YL; Meng EH; Zhang TH; Liu P
Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):483-6. PubMed ID: 12939182
[TBL] [Abstract][Full Text] [Related]
29. Value of autoantibody analysis in the differential diagnosis of chronic cholestatic liver disease.
Milkiewicz P; Buwaneswaran H; Coltescu C; Shums Z; Norman GL; Heathcote EJ
Clin Gastroenterol Hepatol; 2009 Dec; 7(12):1355-60. PubMed ID: 19631286
[TBL] [Abstract][Full Text] [Related]
30. High prevalence of primary biliary cirrhosis and disease-associated autoantibodies in Japanese patients with systemic sclerosis.
Imura-Kumada S; Hasegawa M; Matsushita T; Hamaguchi Y; Encabo S; Shums Z; Norman GL; Takehara K; Fujimoto M
Mod Rheumatol; 2012 Nov; 22(6):892-8. PubMed ID: 22327744
[TBL] [Abstract][Full Text] [Related]
31. [Clinical analysis of primary biliary cirrhosis: a report of 42 cases].
Dai Y; Liang YH; Xie PY; Chen BW; Liu XG
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 37(4):410-4. PubMed ID: 16086064
[TBL] [Abstract][Full Text] [Related]
32. [Baseline analysis of refractory primary biliary cirrhosis].
Wang L; Kong F; Zhang X; Xu D; Hu ZJ; Li YZ; Zhang FC
Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(41):2918-20. PubMed ID: 23328240
[TBL] [Abstract][Full Text] [Related]
33. [Differential characteristics of AMA-M2 autoantibody in primary biliary cirrhosis and non-PBC patients].
Sun L; Wang Y; Liu Y; Zhao Y; Zhang X; Wang Y; Zhao D; Zhang H; Ma Y
Zhonghua Gan Zang Bing Za Zhi; 2015 May; 23(5):343-9. PubMed ID: 26192239
[TBL] [Abstract][Full Text] [Related]
34. [An analysis of the serological characteristics of anti-mitochondrial M2 subtype in patients with drug-induced liver injury and primary biliary cholangitis].
Sun LM; Yan HP; Lou JL; Wang Y; Zhao Y; Yu YH; Zhang HP; Liu YM
Zhonghua Gan Zang Bing Za Zhi; 2019 Apr; 27(4):298-303. PubMed ID: 31082342
[No Abstract] [Full Text] [Related]
35. Is prevalence of PBC underestimated in patients with systemic sclerosis?
Norman GL; Bialek A; Encabo S; Butkiewicz B; Wiechowska-Kozlowska A; Brzosko M; Shums Z; Milkiewicz P
Dig Liver Dis; 2009 Oct; 41(10):762-4. PubMed ID: 19357001
[TBL] [Abstract][Full Text] [Related]
36. The Significance of Autoantibody Changes Over Time in Primary Biliary Cirrhosis.
Tana MM; Shums Z; Milo J; Norman GL; Leung PS; Gershwin ME; Noureddin M; Kleiner DE; Zhao X; Heller T; Hoofnagle JH
Am J Clin Pathol; 2015 Oct; 144(4):601-6. PubMed ID: 26386081
[TBL] [Abstract][Full Text] [Related]
37. Antimitochondrial antibody-negative primary biliary cirrhosis.
Lacerda MA; Ludwig J; Dickson ER; Jorgensen RA; Lindor KD
Am J Gastroenterol; 1995 Feb; 90(2):247-9. PubMed ID: 7847294
[TBL] [Abstract][Full Text] [Related]
38. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
Wu CH; Xu XY; Tian GS; Yu YY
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
[TBL] [Abstract][Full Text] [Related]
39. [Liver histopathology, clinical features and prognostic factors of primary biliary cirrhosis: an analysis of 60 cases].
Yao Y; Xu ZY; Gao JP; Chen XP; Shen LJ; Yang LH; You LY; Yang JH
Zhonghua Gan Zang Bing Za Zhi; 2008 Jun; 16(6):457-60. PubMed ID: 18578999
[TBL] [Abstract][Full Text] [Related]
40. Clinical relevance of combined anti-mitochondrial M2 detection assays for primary biliary cirrhosis.
Han E; Jo SJ; Lee H; Choi AR; Lim J; Jung ES; Oh EJ
Clin Chim Acta; 2017 Jan; 464():113-117. PubMed ID: 27864100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]